Spark Therapeutics ^Investors

Spark Therapeutics is a biotechnology company based in Philadelphia, Pennsylvania, that was founded in 2013 The company focuses on developing gene therapies to treat genetic diseases, with a particular emphasis on inherited retinal diseases and hemophilia Spark Therapeutics has successfully raised significant funding, totaling approximately $161 million, to support its innovative research and development efforts The organization is committed to advancing the field of gene therapy and improving patient outcomes through cutting-edge science and technology